287 related articles for article (PubMed ID: 25977117)
21. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
[TBL] [Abstract][Full Text] [Related]
25. Poor Survival After Retransplantation in NASH Cirrhosis.
Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
[TBL] [Abstract][Full Text] [Related]
26. Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.
Henson JB; Wilder JM; Kappus MR; Barbas AS; Moylan CA; Niedzwiecki D; Muir AJ; Berg CL; Patel YA
Transplantation; 2020 Jun; 104(6):e164-e173. PubMed ID: 32150036
[TBL] [Abstract][Full Text] [Related]
27. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
[TBL] [Abstract][Full Text] [Related]
28. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME
Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
Carter D; Dieterich DT; Chang C
Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
[TBL] [Abstract][Full Text] [Related]
30. The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI.
Lee DU; Bahadur A; Ponder R; Lee KJ; Fan GH; Chou H; Lominadze Z
Hepatol Int; 2023 Dec; 17(6):1393-1415. PubMed ID: 37160862
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
[TBL] [Abstract][Full Text] [Related]
32. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
34. Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients With Nonalcoholic Steatohepatitis.
Dutta N; Marka N; Lake J; Lim N
Transplant Proc; 2023 Nov; 55(9):2023-2026. PubMed ID: 37730450
[TBL] [Abstract][Full Text] [Related]
35. Impact of living donor liver transplantation on long-term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis.
Karnam RS; Azhie A; Yang C; Rogalsky A; Chen S; Xu W; Patel K; Selzner N; Lilly L; Cattral M; Bhat M
Clin Transplant; 2023 Sep; 37(9):e15008. PubMed ID: 37143204
[TBL] [Abstract][Full Text] [Related]
36. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge.
Steggerda JA; Mahendraraj K; Todo T; Noureddin M
World J Gastroenterol; 2020 Jul; 26(28):4018-4035. PubMed ID: 32821068
[TBL] [Abstract][Full Text] [Related]
37. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?
Houlihan DD; Armstrong MJ; Davidov Y; Hodson J; Nightingale P; Rowe IA; Paris S; Gunson BK; Bramhall SB; Mutimer DJ; Neuberger JM; Newsome PN
Liver Transpl; 2011 Nov; 17(11):1292-8. PubMed ID: 21761549
[TBL] [Abstract][Full Text] [Related]
38. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes.
Grupper A; Rabinowich A; Ben Shabat I; Tzadok R; Schwartz D; Schwartz IF; Goykhman Y; Kliuk Ben-Bassat O; Baruch R; Shashar M; Cohen-Hagai K; Katchman H
Am J Nephrol; 2022; 53(8-9):636-645. PubMed ID: 36075195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
